Nationwide Uniform Scientific Evaluation of Flexible and Integrated Treatment Projects From 2022 Onwards
Launched by TECHNISCHE UNIVERSITÄT DRESDEN · May 4, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to mental health care called Flexible and Integrated Treatment (FIT). The goal is to find out if this type of care is better than standard mental health services. FIT aims to provide more personalized and adaptable treatment options, allowing patients to receive the right level of care based on their unique needs. This trial will involve various psychiatric hospitals in Germany and will evaluate both new FIT projects starting in 2022 and existing ones that have been extended.
To participate in the trial, individuals must be treated at one of the hospitals involved and have insurance from one of the participating health insurance providers. Participants can expect to be part of a study that compares their experiences with FIT care against those receiving standard treatment. It's important to note that only individuals who have at least one year of follow-up data will be included in the study. This research aims to improve mental health care for everyone by understanding the benefits of more flexible treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • treatment in any of the participating hospitals or control hospitals within recruitment phase (number of hospitals will be fix until June 2026)
- • being insured with any of the participating SHI funds
- Exclusion Criteria:
- • less than one year follow-up data available
About Technische Universität Dresden
Technische Universität Dresden (TU Dresden) is a leading research institution in Germany, renowned for its commitment to advancing scientific knowledge and innovation across various disciplines, including medicine and healthcare. As a clinical trial sponsor, TU Dresden leverages its cutting-edge research facilities and interdisciplinary expertise to facilitate the development of novel therapeutic interventions and improve patient outcomes. The university fosters collaboration among academic, clinical, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in the conduct of clinical research. Through its dedication to excellence and research-driven initiatives, TU Dresden plays a pivotal role in translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Magdeburg, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported